Factbox-Vaccines delivered under COVAX sharing scheme for poorer countries

Reuters
·9 min read
FILE PHOTO: Nurse prepares to administer the AstraZeneca/Oxford vaccine against the COVID-19 at the Eka Kotebe General Hospital in Addis Ababa

(Reuters) - The COVAX facility, backed by the World Health Organization (WHO) and the Global Alliance for Vaccines and Immunization (GAVI), has delivered 1.63 billion COVID-19 vaccine doses to 146 countries, GAVI data shows.

In December, COVAX set a target of achieving 70% COVID-19 immunization coverage by mid-2022.

The following tables list countries that have received vaccines under the scheme in alphabetic order:

AFRICA & MIDDLE EAST

COUNTRY LATEST DELIVERY DATE VACCINE TYPE POPULATION TOTAL

DELIVERY DELIVERED

Algeria 3.6 million December 24 J&J 44 million 6.0 million

Angola 801,000 December 25 Pfizer/BioNTech 33 million 14.8 million

Benin 336,000 November 4 J&J 12 million 1.1 million

Botswana 300,000 October 1 AstraZeneca/Oxford 2.5 million 560,460

Burkina Faso 700,000 May 1 Pfizer/BioNTech 21 million 1.8 million

Cameroon 68,600 April 1 AstraZeneca/Oxford 27 million 1.1 million

Cape Verde 200,000 December 7 Pfizer/BioNTech 556,000 324,000

Central 168,300 March 4 N/A 4.8 million 975,000

African

Republic

Chad 828,000 March 24 J&J 16 million 1.0 million

Comoros 90,000 May 8 Pfizer/BioNTech 870,000 360,810

Islands

Congo 168,000 November 15 J&J 5.5 million 470,400

Democratic 2.1 million June 28 N/A 90 million 4.7 million

Republic of

Congo

Djibouti 151,200 July 17 J&J 988,000 175,200

Egypt 1.5 million April 7 Pfizer/BioNTech 102 million 30.5 million

Eswatini 100,620 October 6 Pfizer/BioNTech 1.1 million 429,420

Equatorial 60,480 June 1 Moderna 1.4 million 60,480

Guinea

Ethiopia 13.1 February 2 J&J 115 million 27.5 million

million

Gabon 101,790 November 1 Pfizer/BioNTech 2.2 million 370,410

Gambia 100,620 March 3 Pfizer/BioNTech 2.4 million 477,420

Ghana 309,600 March 14 AstraZeneca/Oxford 31 million 16.6 million

Guinea 168,000 November 14 J&J 13 million 1.7 million

Guinea-Bissau 136,800 March 25 J&J 2.0 million 496,800

Iran 700,000 January 14 AstraZeneca/Oxford 84 million 5.7 million

Iraq 500,000 August 14 Pfizer/BioNTech 40 million 836,000

Ivory Coast 816,660 January 3 Pfizer/BioNTech 26 million 8.6 million

Jordan 146,400 June 3 AstraZeneca/Oxford 10 million 436,800

Kenya 500,000 May 10 Pfizer/BioNTech 54 million 20.3 million

Lebanon 613,340 December 22 N/A 6.8 million 982,940

Lesotho 169,070 November 19 J&J 2.1 million 644,090

Liberia 583,200 June 1 J&J 5.1 million 2.0 million

Libya 1.2 million December 20 Pfizer/BioNTech 6.9 million 1.9 million

Madagascar 240,000 February 17 J&J 28 million 1.9 million

Malawi 277,080 February 26 AstraZeneca/Oxford 19 million 2.0 million

Mali 58,500 June 15 Pfizer/BioNTech 20 million 2.8 million

Mauritania 57,330 June 2 Pfizer/BioNTech 4.6 million 2.2 million

Mauritius 203,580 January 12 Pfizer/BioNTech 1.3 million 387,270

Morocco 1.5 million January 29 Pfizer/BioNTech 37 million 2.7 million

Mozambique 1.2 million February 11 AstraZeneca/Oxford 31 million 8.4 million

Namibia 19,890 February 18 Pfizer/BioNTech 2.5 million 512,690

Niger 398,000 February 4 Pfizer/BioNTech 24 million 1.6 million

Nigeria 2.6 million August 1 J&J 206 million 19.8 million

Palestinian 197,730 July 25 N/A 4.7 million 1.8 million

Territories

Rwanda 254,400 June 27 N/A 13 million 4.2 million

Sao Tome and 24,000 March 3 AstraZeneca/Oxford 219,000 24,000

Principe

Senegal 300,000 March 31 AstraZeneca/Oxford 17 million 3.5 million

Seychelles 39,780 December 17 Pfizer/BioNTech 98,460 74,880

Sierra Leone 168,000 November 23 J&J 8.0 million 785,310

Somalia 115,150 July 28 Pfizer/BioNTech 16 million 2.0 million

South Africa 5.6 million July 31 Pfizer/BioNTech 59 million 5.6 million

South Sudan 578,400 August 10 N/A 11 million 2.8 million

Sudan 604,800 February 16 J&J 44 million 3.9 million

Syria 4.0 million January 26 J&J 17 million 5.7 million

Tanzania 1.4 million August 1 J&J 60 million 8.9 million

Togo 633,600 November 25 J&J 8.3 million 3.0 million

Tunisia 599,040 March 31 N/A 12 million 5.4 million

Uganda 2.9 million March 9 J&J 46 million 14.6 million

Yemen 100,800 February 24 AstraZeneca/Oxford 30 million 2.2 million

Zambia 950,350 June 30 J&J 18 million 5.4 million

Zimbabwe 2.6 million January 19 N/A 15 million 3.5 million

EUROPE

COUNTRY LATEST DELIVERY VACCINE TYPE POPULATION TOTAL

DELIVERY DATE DELIVERED

Albania 40,800 June 2 AstraZeneca/Oxford 2.8 million 120,000

Armenia 187,200 September 5 AstraZeneca/Oxford 3.0 million 261,200

Azerbaijan 84,000 April 4 AstraZeneca/Oxford 10 million 84,000

Bosnia 32,760 May 10 Pfizer/BioNTech 3.3 million 82,560

Georgia 43,200 March 13 AstraZeneca/Oxford 3.7 million 43,200

Kosovo 4,800 June 22 N/A 1.8 million 1.2 million

Moldova 100,620 January 27 Pfizer/BioNTech 2.6 million 744,620

Montenegro 24,000 March 28 AstraZeneca/Oxford 622,000 24,000

North 250,380 February 7 Pfizer/BioNTech 2.1 million 312,780

Macedonia

Serbia 115,200 August 25 AstraZeneca/Oxford 6.9 million 292,800

J&J

Ukraine 100,000 August 23 44 million 8.9 million

ASIA & PACIFIC

COUNTRY LATEST DELIVERY DELIVERY VACCINE TYPE POPULATION TOTAL

DATE DELIVERED

Afghanistan 2.0 million February 2 J&J 39 million 9.0 million

Bangladesh 4.1 million June 27 N/A 165 million 38.9 million

Bhutan 90,090 April 5 Pfizer/BioNTech 771,612 90,090

Brunei 24,000 April 2 AstraZeneca/Oxford 437,000 24,000

Cambodia 2.0 million May 3 Pfizer/BioNTech 17 million 4.9 million

East Timor 100,620 February 12 Pfizer/BioNTech 1.3 million 494,040

Fiji 9,600 July 15 Moderna 896,000 321,680

Indonesia 3.5 million March 5 Pfizer/BioNTech 274 million 52.3 million

Kiribati 19,890 July 20 Pfizer/BioNTech 119,000 147,290

Kyrgyzstan 149,760 February 1 Pfizer/BioNTech 6.6 million 800,300

Laos 1.7 million January 26 Pfizer/BioNTech 7.3 million 7.6 million

Malaysia 559,200 September AstraZeneca/Oxford 32 million 1.4 million

17

Maldives 100,000 August 10 N/A 541,000 764,540

Mongolia 302,400 June 21 Pfizer/BioNTech 3.3 million 1.6 million

Nauru 7,200 April 2 AstraZeneca/Oxford 10,830 7,200

Nepal 2.8 million August 9 N/A 29 million 18.5 million

Pakistan 4.7 million April 12 Pfizer/BioNTech 221 million 43.8 million

Papua New 302,400 August 6 J&J 8.9 million 580,400

Guinea

Philippines 299,520 June 27 Pfizer/BioNTech 110 million 56.9 million

Samoa 45,630 May 2 Pfizer/BioNTech 198,410 181,630

Solomon 35,100 August 17 Pfizer/BioNTech 687,000 297,170

Islands

Sri Lanka 820,000 December 20 Pfizer/BioNTech 22 million 5.0 million

Tajikistan 122,850 August 22 Pfizer/BioNTech 9.5 million 7.0 million

Tonga 7,000 February 15 N/A 106,000 67,800

Tuvalu 4,800 April 8 AstraZeneca/Oxford 11,800 4,800

Uzbekistan 2.0 million July 4 Pfizer/BioNTech 34 million 21.0 million

Vanuatu 20,400 April 8 Moderna 307,000 44,400

Vietnam 3.5 million April 19 Pfizer/BioNTech 97 million 50.0 million

AMERICAS

COUNTRY LATEST DELIVERY VACCINE TYPE POPULATION TOTAL

DELIVERY DATE DELIVERED

Antigua and 19,200 November 22 N/A 98,000 60,000

Barbuda

Argentina 960,400 October 12 AstraZeneca/Oxford 45 million 3.9 million

Bahamas 24,000 July 23 Pfizer/BioNTech 393,000 182,130

Barbados 14,040 December 16 Pfizer/BioNTech 287,000 114,840

Belize 58,500 October 26 Pfizer/BioNTech 398,000 159,300

Bermuda 9,600 April 6 AstraZeneca/Oxford 64,000 9,600

Bolivia 603,720 April 28 Pfizer/BioNTech 12 million 8.6 million

Brazil 2.0 million September 20 Sinovac 213 million 11.9 million

Chile 331,000 May 20 AstraZeneca/Oxford 19 million 489,400

Colombia 1.7 million July 11 Sinovac 51 million 27.8 million

Costa Rica 200,070 February 28 Pfizer/BioNTech 5.1 million 1.6 million

Dominica 30,240 February 4 Moderna 72,000 133,920

Dominican 184,800 August 27 AstraZeneca/Oxford 11 million 463,200

Republic

Ecuador 1.5 million February 15 Pfizer/BioNTech 18 million 3.8 million

El Salvador 297,600 August 11 Pfizer/BioNTech 6.5 million 3.9 million

Grenada 4,800 July 27 Pfizer/BioNTech 113,000 129,510

Guatemala 349,830 June 27 Pfizer/BioNTech 17 million 5.9 million

J&J

Guyana 28,800 August 19 787,000 410,760

11

Haiti 99,450 August 25 Pfizer/BioNTech million 1.3 million

Honduras 205,920 August 24 Pfizer/BioNTech 9.9 million 7.4 million

Jamaica 398,970 March 21 Pfizer/BioNTech 3.0 million 1.9 million

Mexico 4.0 March 4 AstraZeneca/Oxford 129 million 21.3 million

million

Nicaragua 650,600 July 9 Pfizer/BioNTech 6.6 million 6.5 million

Panama 74,400 September 15 AstraZeneca/Oxford 4.3 million 148,800

Paraguay 466,830 January 24 Pfizer/BioNTech 7.1 million 1.7 million

Peru 1.2 million November 10 Sinopharm 33 million 3.6 million

Saint Kitts and 21,600 April 7 AstraZeneca/Oxford 53,000 21,600

Nevis

Saint Lucia 4,800 August 3 Pfizer/BioNTech 184,000 207,270

Saint Vincent 4,800 July 8 Pfizer/BioNTech 111,000 130,680

and the

Grenadines

Suriname 64,800 December 14 AstraZeneca/Oxford 587,000 144,000

Trinidad and 84,000 November 27 Sinopharm 1.4 million 185,200

Tobago

Uruguay 50,400 September 1 AstraZeneca/Oxford 3.5 million 148,800

Venezuela 4.7 million March 14 Sinopharm 28 million 16.8 million

Sources: WHO, UNICEF, GAVI, releases from local authorities

(Compiled by Marta Frackowiak, Antonis Pothitos, Boleslaw Lasocki, Antonis Triantafyllou, Aleksandra Jasiurska and Elizaveta Gladun; editing by Jason Neely/Mark Heinrich)